Centre Manager, UK NEQAS for Leucocyte Phenotyping (LI)
UK NEQAS Board Divisional Representative Haematology Division
Vice President for Working Group
PROFESSIONAL CAREER
10 years experience in a busy regional genetics service culminating in appointment as the lead for the Haemato-oncology genetics service
15 years working for UK NEQAS starting as a clinical scientist advancing to the position of Centre Manager
Centre Manager role involves managing the delivery of EQA services to flow cytometric and molecular haemato-oncology laboratories both nationally and internationally. This involves the ongoing delivery of 25 EQA programmes; liaison with participants to resolve incidences of poor performance; the reporting of poor performance to a number of national oversight committees; and the design and development of new EQA programmes. In addition, the Centre Manager role involves taking a lead in the implementation of scientific and technical research, service development within the organisation and managing the administration and scientific departments. In addition, I'm currently several years into a PhD project comparing different methods of measuring MRD in Plasma Cell Myeloma and assessing the impact of any variation on patient management
OTHER PROFESSIONAL ROLES INCLUDE
Chair of MRD AML Standardisation Working Group (2022)
UK NHSEI Acute Myeloid Leukaemia Measurable Residual Disease Working Group (2021-current)
Novartis UK Myeloid-Leukaemia Molecular Monitoring Steering Committee (2018)
Member of the European LeukaemiaNet Acute Myeloid Leukaemia Minimal Residual Disease Working Group member (2019)
Specialist Advisor to the Royal College of Pathologists National Quality Assurance Advisory Panel for Genetics (2014-current)
Advisor to the Technical Working Group Review of WHO Manual for Establishment of National EQA Scheme for Testing Centres (2015)
Author /co author of a number of scientific peer reviewed publications covering various aspects of haemato-oncology genetics
